A new, low-cost Texas Children’s Hospital vaccine gets approval for use in India

A COVID-19 vaccine created at the Texas Children's Hospital Center for Vaccine Development in Houston has received emergency use authorization in India, after nearly 10 years of research and funding obstacles in 2020.

The goal is to make the vaccine – called Corbevax – available in other low- and middle-income nations across the globe to help prevent future variants of concern from forming.

“As long as we leave the southern hemisphere unvaccinated new variants of concern for us will emerge," said Dr. Peter Hotez, co-director of the Texas Children's Hospital Center for Vaccine Development and dean at Baylor's National School of Tropical Medicine. “The only way to stop it is to vaccinate the world and we think our [vaccine] is going to be a major contributor to that."

Johnson & Johnson's Covid-19 vaccine is 73.6% effective, according to new real-world study Data from a real-world study assessing Johnson & Johnson's Covid-19 vaccine finds it is 73.6% effective, according to research published Tuesday in the journal JAMA Network Open. John Bonifield, CNN CNN

...